- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2013 (2013), Article ID 476240, 7 pages
PTPIP51: A New Interaction Partner of the Insulin Receptor and PKA in Adipose Tissue
1Institute of Anatomy and Cell Biology, Justus Liebig University Giessen, Aulweg 123, 35392 Giessen, Germany
2Department of Neurology, Justus Liebig University Giessen, 35392 Giessen, Germany
3Department of Sports Medicine, Justus Liebig University Giessen, 35394 Giessen, Germany
Received 5 November 2012; Accepted 8 February 2013
Academic Editor: Francesco Saverio Papadia
Copyright © 2013 M. A. Bobrich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Aims. Our previous experiments revealed an association of PTPIP51 (protein tyrosine phosphatase interacting protein 51) with the insulin signalling pathway through PTP1B and 14-3-3beta. We aimed to clarify the role of PTPIP51 in adipocyte metabolism. Methods. Four groups of ten C57Bl/6 mice each were used. Two groups were fed a standard diet; two groups were fed a high-fat diet. Two groups (one high-fat diet and one standard diet) were submitted to endurance training, while the remaining two groups served as untrained control groups. After ten weeks, we measured glucose tolerance of the mice. Adipose tissue samples were analyzed by immunofluorescence and Duolink proximity ligation assay to quantify interactions of PTPIP51 with either insulin receptor (IR) or PKA. Results. PTPIP51 and the IR and PTPIP51 and PKA, respectively, were colocalized in all groups. Standard diet animals that were submitted to endurance training showed low PTPIP51-IR and PTPIP51-PKA interactions. The interaction levels of both the IR and PKA differed between the feeding and training groups. Conclusion. PTPIP51 might serve as a linking protein in adipocyte metabolism by connecting the IR-triggered lipogenesis with the PKA-dependent lipolysis. PTPIP51 interacts with both proteins, therefore being a potential gateway for the cooperation of both pathways.
Obesity abets several life style diseases such as diabetes type II, atherosclerosis, or impaired wound healing. These adverse effects can be avoided or, if already present, reduced by physical activity. Physical activity increases sympathetic activity and blood catecholamine levels. Adaption to periodic physical exercise is well studied. Exercise training and increased catecholamine levels affect adipocyte metabolism, on one hand by influencing insulin secretion  and on the other hand by additionally channelling the adipocyte metabolism towards lipolysis . This effect is mediated by beta2-adrenergic receptors which activate the intracellular adenylyl cyclase. Adenylyl cyclase transforms ATP into cyclic AMP (cAMP), which in turn increases the activity level of cAMP-dependent protein kinase A (PKA) [3, 4]. Protein kinase A thereupon initiates lipolysis .
The most potent antagonist of catecholamines on adipose tissue is insulin. Activation of the insulin receptor results in decreased lipolysis, increased lipogenesis and uptake of fatty acids.
Lipolysis is decreased by insulin-receptor-induced phosphodiesterase-3B (PDE-3B) and 14-3-3beta-dependent reduction of PKA activity [3, 5]. Furthermore, the insulin receptor activates several lipogenic enzymes by tyrosine phosphorylation and promotes GLUT-4 recruitment to the cell membrane .
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) is expressed in different organs with a multitude of functions [7, 8]. As previously shown for mouse adipose tissue, PTPIP51 acts as an effector in insulin signalling. PTPIP51 expression was correlated to the insulin resistance of the animals , according to the expression of its interaction partner protein tyrosine phosphatase 1B (PTP1B). In addition to that, PTPIP51 is connected to the lipolytic MAPK pathway by its interaction with raf-1 mediated by 14-3-3beta . 14-3-3beta also interacts with phosphodiesterase 3B, resulting in reduced intracellular cAMP levels and decreased PKA activity . As 14-3-3beta and PTP1B are important for adipocyte metabolism control, the role of its interaction partner PTPIP51 needs to be disclosed.
The interaction of PTPIP51 with the insulin receptor and PKA was investigated in adipose tissue from animals kept under different defined experimental conditions to search for a potential role of PTPIP51 in adipocyte metabolism.
2. Material and Methods
2.1. Study Design
The experiments were performed with male C57Bl/6 mice () and approved by the local Animal Care and Use Committee (Gi 20/24 Nr. 94/2010). The animals were kept under standard conditions (12 h light/dark cycle) with no access to running wheels. They were fed ad libitum with free access to water. The animals were aged ten weeks at the beginning of the training. The experiments were run for 14 weeks, with a four-week period of fat feeding followed by a ten-week training period.
Control group (SD): the animals were fed a standard diet (Altromin standard diet no. 1324, Altromin, Lage, Germany).
Endurance training control group (SDT): the animals were fed a standard diet (Altromin standard diet no. 1324, Altromin, Lage, Germany) and trained for a period of ten weeks. The training was performed on a motorized treadmill for 35 min/day at 12 m/min, at 12% grade, 5 times per week, for ten weeks. Running speed was 0.27 m/s corresponding to 80% of maximal oxygen consumption.
High-fat-diet group (HFD): the animals were fed a high-fat diet containing 45% fat for 14 weeks of the experimental period.
High-fat-diet, training group (HFDT): The animals were fed a high-fat-diet during the complete experimental time period. The endurance training period started four weeks after the beginning of high-fat-diet feeding and was similar to the training described above.
For diet composition, see Table 1.
After 14 weeks, the animals were sacrificed in the morning between 10 and 12 o’clock and the abdominal adipose tissue was frozen in liquid nitrogen precooled isopentan, and transferred to −80°C till further analysis. See also Bobrich et al. . A glucose tolerance test was performed to determine the insulin sensitivity of the mice [9–11]. For testing the glucose tolerance of the animals, they were injected intraperitoneally with 2 g of 20% D-glucose dissolved in sterile 0.9% NaCl solution per kg body weight. The blood was collected and glucose concentration was determined. The test was performed in the morning; last feeding of the animals took place the previous day.
2.2. PTPIP51 Antibody Production
An antibody against a defined peptide sequence at the C-terminus of PTPIP51 (sequence: IQKDLEELEVILRD, exon 13) was produced (BioLux, Stuttgart, Germany). Identity and purity of the synthesized peptide were approved by ESI-MS and UV-analysis. Rabbits were immunized with the KLH-conjugated peptide. The specificity of the antibody was tested by ELISA and Western blot. Preabsorption experiments were performed [9, 12].
Immunofluorescence staining was performed according to a standard protocol . The primary PTPIP51 antibody to the C-terminus was used in 1 : 800 dilutions and visualized by Alexa 555 (Molecular Probes, Darmstadt, Germany, Cat. no. A21428). Primary monoclonal mouse antibodies were used for double staining experiments with PKA (ab58187, Abcam plc, 330 Cambridge Science Park, Cambridge, UK) and the beta-subunit of the IR (clone CT-3, Millipore, 28820 Single Oak Drive, Temecula, CA, USA). To avoid unspecific binding of the primary mouse antibodies, samples were preincubated with biotin-coupled anti-mouse-antibodies for one hour. The reaction of the primary monoclonal mouse antibody was visualized using Alexa fluor 488 secondary antibodies (Molecular Probes, Darmstadt, Germany, Cat. no. A11001).
2.4. Confocal Laser Scanning Microscopy
Confocal images of cells were obtained with a Leica confocal laser scanning microscope (CLSM, 5 TCS SP2, Leica, Bensheim, Germany). Confocal images of Alexa Fluor 555 fluorescence were acquired using 6 Plan-Apochromat × 40/1.4 oil objective, 548 nm excitation wavelengths (helium-neon laser), and a 560–585 nm band-pass filter. The pinhole diameter was set to yield optical sections of 1 airy unit. For the detection of Alexa Fluor 488, we used a Plan-Apochromat × 40/1.4 oil objective, the 488 nm excitation wavelength of an argon laser, and a 505–530 nm band-pass filter. The pinhole diameter was set to yield optical sections of 1 Airy unit. Confocal images of To-Pro-3 fluorescence (Molecular probes, Cat. no. T3605) (nuclear staining) were acquired using Plan-Apochromat × 40/1.4 oil objective, 633 nm excitation wavelengths (helium-neon laser), and the 650–670 nm bandpass filter. The pinhole diameter was set to yield optical sections of 1 Airy unit. Acquired DIC and confocal images were analyzed and combined using the LCS software (Leica Confocal Software).
Acquired images were subsequently processed by ImageJ (v1.43 m; Rasband, W.S., ImageJ, US National Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997–2011) using an iterative deconvolution plug-in by Bob Dougherty (http://www.optinav.com/imagej.html, Iterative Deconvolution). Options were set for all confocal acquired images as follows: 8 numbers of iteration and 2.0 pixels of LP filter diameter. Point spread function was calculated for each channel separately by the ImageJ plug-in created by Bob Dougherty (http://www.optinav.com/imagej.html, Diffraction Limit PSF).
2.5. Intensity Correlation Analysis
Intensity correlation analysis (ICA) was carried out using ImageJ (v1.43 m; Rasband, W.S., ImageJ, US National Institutes of Health, Bethesda, MD, USA, http://imagej.nih.gov/ij/, 1997–2011) and an appropriate plug-in for ICA included in the plug-in package of the Wright cell imaging facility  (http://www.uhnres.utoronto.ca/facilities/wcif/fdownload.html).
2.6. Duolink Proximity Ligation Assay (DPLA)
Interaction of PTPIP51 with either PKA or beta-subunit of the IR was detected by the proximity ligation assay kit Duolink (Olink |Bioscience, Uppsala, Sweden, PLA probe anti-rabbit minus for the detection of the rabbit PTPIP51 antibody, Cat. no. 90602; PLA probe anti-mouse PLUS for the detection of the mouse anti PKA or IR antibody, Cat. no. 90701; Detection Kit 563, Cat. no. 90134).
2.7. Fluorescence Microscopy
The Axioplan 2 fluorescence microscope equipped with Plan-Apochromat objectives (Carl Zeiss Jena, Germany) was used for photo documentation. For visualization of the DPLA, an excitation filter with a spectrum of 530–560 nm and an emission filter with a spectrum of 572–647 nm were used.
2.8. Analysis of Duolink Proximity Ligation Assay Results
The Duolink Image Tool (Olink biosciences, Uppsala, Sweden) was used for quantification of the detected DPLA signals. All analyzed sections were investigated with equal light intensity and shutter speed. Sensitivity of the software scan and blob threshold were set identically for all probes. The positive reaction dots were counted automatically.
2.9. Database Research
We accomplished a database research using the GPS 2.1 database  to identify kinases within adipocyte metabolism that possess the ability to phosphorylate PTPIP51.
2.10. Statistical Analysis
The observed data were analysed by nonparametrical tests to determine the significance of the results.
3.1. Glucose Tolerance Test and Mean Body Weight
The glucose tolerance was determined by a standard glucose tolerance test at the end of the experimental period. SD and SDT animals displayed a slight increase of blood glucose levels 30 minutes after application of glucose which was almost normalized after 60 minutes.
In HFD animals, blood glucose levels strongly increased from the basal level of 100 mg/dL to 400 mg/dL 60 minutes after application. Blood glucose levels did not return to normal values within 120 minutes.
In HFDT animals, blood glucose levels increased to 270 mg/dL 30 minutes after application and almost returned to normal values after 120 minutes (Figure 2). The values of HFD, HFDT, and animals fed a standard diet (SD and SDT) are significantly different after 30 and 60 minutes. After 120 minutes, the differences between standard diet and high fat diet animals remained significant, whereas there was no significant difference between standard diet and trained high-fat-diet animals.
Mean body weight was measured at different time points throughout the test (see Table 2).
Statistical analysis showed that there was no significant difference between the four groups at 10 weeks of age. From the beginning of the training, the difference between standard diet and high-fat-diet-fed groups was highly significant, but there was no significant difference between the SD and SDT and, respectively HFD and HFDT groups.
3.2. PTPIP51 Protein Is Colocalized with the Insulin Receptor (IR) and Protein Kinase A (PKA)
PTPIP51 localization in adipose tissue did not differ between the four experimental setups. PTPIP51 immunoreactivity was detected within the cytoplasm and at the plasma membrane (Figure 3).
The IR revealed a similar expression pattern when compared to PTPIP51. In the cytoplasm, the immune reaction of the IR antibody was lower compared to PTPIP51. The computed data of the intensity correlation analysis is displayed in Figure 3(B). Colocalization is displayed in yellow to orange and noncolocalized parts are shown in blue. Most colocalization was detected at the plasma membrane.
PKA is also colocalized with PTPIP51, especially concerning its expression in the cytoplasm. The computed data of the intensity correlation analysis is displayed in Figure 3(D). Co-localization is displayed in yellow to orange and non-co-localized parts are shown in blue. Most colocalization was detected within the cytoplasm.
3.3. PTPIP51 and IR Interact and the Interaction Depends on the Feeding Status
The Duolink proximity ligation assay (DPLA) was performed to detect interactions between PTPIP51 and the beta-subunit of the IR. The interaction of PTPIP51 and IR was verified as seen in Figure 4, where each dot indicates the interaction of both proteins. This interaction of PTPIP51 and the IR was found in the adipocytes of animals from all experimental groups. Specificity of the DPLA was tested (Figure 4).
The grade of interaction in adipose samples from SD animals corresponds to the level in HFDT animals. A decrease in the interaction was detected in samples from SDT animals. HFD animals displayed the highest interaction level (Figure 5(a)).
3.4. Interaction between PTPIP51 and PKA Displayed a Dependency on Training Status
The Duolink proximity ligation assay was performed to detect interactions between PTPIP51 and PKA. The assumption of an interaction of PTPIP51 and PKA based on the database research was verified (Figure 4). PTPIP51 and PKA were interacting in adipocytes of animals from all experimental groups.
The interaction levels of SD, HFD, and HFDT mice did not show significant differences. The interaction levels seen in SDT mice were decreased (Figure 5(b)).
To sum up the results, adipocytes from mice subjected to different diets and activity levels displayed a connection between PTPIP51 and the insulin receptor, and PTPIP51 and PKA respectively. Animals of the four experimental groups displayed differences in their glucose resistance. The glucose-tolerance test revealed a glucose-intolerant status in HFD and HFDT animals, whereas the glucose tolerance of HFDT animals improved compared to HFD animals.
Immunofluorescence data displayed colocalization of PTPIP51 with IR and PKA suggesting an interaction between PTPIP51 and IR, and PTPIP51 and PKA respectively. Basing on these facts, we performed a GPS 2.1 database research. Search results displayed PTPIP51 to be phosphorylated at tyrosine 176 by the insulin receptor and at serine 46 by PKA . These two phosphorylation sites are possible regulatory sites for the interaction of PTPIP51 with 14-3-3beta, thus being able to influence the MAPK pathway by interaction with raf-1 . Phosphorylation of Serine 46 in PTPIP51 results in augmented interaction with raf-1 via 14-3-3 and thus in increased ERK1/2 phosphorylation, promoting the MAPK pathway [12, 17]. The MAPK pathway is suspected to possess two opposite functions in adipocytes. Depending on the activator, ERK1/2 conveys either adipocyte growth or lipolysis . PKA is known to induce lipolysis through the MAPK pathway [18, 19].
The insulin receptor induces tyrosine phosphorylation of PTPIP51 at tyrosine 176, which leads to reduced interaction of PTPIP51 with 14-3-3beta and raf-1 , thereby decreasing the MAPK pathway activity.
Analysis of the PTPIP51 interaction profile of adipocytes displayed high interaction levels with the insulin receptor in HFD animals. Interaction levels were reduced by 30% in SD and HFDT and by 50% in SDT animals, compared to HFD animals.
High-fat feeding increases the lipogenic activity in adipose tissue [21, 22]. This is consistent with our observation of high interaction levels in HFD animals. Training leads to reduced adipocyte size . The reduced PTPIP51-IR interaction in trained groups compared to the corresponding untrained groups suggests that PTPIP51 is especially involved in the processes of insulin induced lipogenesis or in its antilipolytic action.
Interaction levels between PTPIP51 and PKA did not show significant differences in SD, HFD, and HFDT animals. In SDT animals, the interaction was reduced.
The low interaction in SDT animals seems to be controversial. But, as PKA also interacts with the hormone-sensitive lipase (HSL), a change of the interaction partner of PKA away from PTPIP51 under these preconditions is assumable. The interaction between PKA and HSL is a potent promoter for lipolysis in adipocytes. The activities of both PKA and HSL are increased in endurance-trained animals [24, 25].
Our experiments suggest that PTPIP51 could mediate between lipogenesis and lipolysis by switching between the lipogenic insulin pathway and the lipolytic PKA pathway. Further experiments need to be conducted in order to prove our hypothesis and to determine the magnitude in which PTPIP51 engages in adipocyte metabolism.
|PKA:||cAMP-activated protein kinase A|
|DPLA:||Duolink proximity ligation assay|
|HFDT:||High-fat diet and training|
|MAPK:||Mitogen-activated protein kinase|
|PTPIP51:||Protein tyrosine phosphatase interacting protein 51|
|SDT:||Standard diet and training.|
This publication is dedicated to Mr. Hans Werner Hofer who promoted the research on PTPIP51 with all his energy. He died much too early († 2011-05-18).
Conflict of Interests
There is no conflict of interests to declare.
S. Schwabe, A. Brobeil, M. Viard, M. Kamm and C. Tag performed experiments and revised the paper. F. C. Mooren, K. Krüger, and M. Wimmer revised the paper and designed the study. M. Bobrich designed the study, performed experiments, and wrote and revised the paper.
- K. L. Teff, “Visceral nerves: vagal and sympathetic innervation,” Journal of Parenteral and Enteral Nutrition, vol. 32, no. 5, pp. 569–571, 2008.
- T. Leskinen, R. Rinnankoski-Tuikka, M. Rintala et al., “Differences in muscle and adipose tissue gene expression and cardio-metabolic risk factors in the members of physical activity discordant twin pairs,” PLoS ONE, vol. 5, no. 9, Article ID e12609, 2010.
- M. Lafontan, “Advances in adipose tissue metabolism,” International Journal of Obesity, vol. 32, supplement 7, pp. S39–S51, 2008.
- G. Mantovani, S. Bondioni, L. Alberti et al., “Protein kinase A regulatory subunits in human adipose tissue: decreased R2B expression and activity in adipocytes from obese subjects,” Diabetes, vol. 58, no. 3, pp. 620–626, 2009.
- A. Aitken, “14-3-3 proteins: a historic overview,” Seminars in Cancer Biology, vol. 16, no. 3, pp. 162–172, 2006.
- S. Kersten, “Mechanisms of nutritional and hormonal regulation of lipogenesis,” EMBO Reports, vol. 2, no. 4, pp. 282–286, 2001.
- P. S. Koch, M. Viard, A. Stenzinger et al., “Expression profile of PTPIP51 in mouse brain,” Journal of Comparative Neurology, vol. 517, no. 6, pp. 892–905, 2009.
- A. Stenzinger, D. Schreiner, P. Koch, H. W. Hofer, and M. Wimmer, “Chapter 6 cell and molecular biology of the novel protein tyrosine-phosphatase-interacting protein 511,” International Review of Cell and Molecular Biology, vol. 275, pp. 183–246, 2009.
- M. Bobrich, A. Brobeil, F. C. Mooren et al., “PTPIP51 interaction with PTP1B and 14-3-3β in adipose tissue of Insulin-resistant mice,” International Journal of Obesity, vol. 35, pp. 1385–1394, 2011.
- S. Fukuda, T. Ohta, S. Sakata et al., “Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551,” Diabetes, Obesity and Metabolism, vol. 12, no. 4, pp. 299–306, 2010.
- M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999.
- A. Brobeil, M. Graf, S. Oeschger, K. Steger, and M. Wimmer, “PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes,” Blood Cells, Molecules, and Diseases, vol. 45, no. 2, pp. 159–168, 2010.
- Q. Li, A. Lau, T. J. Morris, L. Guo, C. B. Fordyce, and E. F. Stanley, “A syntaxin 1, Gαo, and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization,” Journal of Neuroscience, vol. 24, no. 16, pp. 4070–4081, 2004.
- M. Gullberg and A. C. Andersson, “Visualization and quantification of protein-protein interactions in cells and tissues,” Nature Methods, vol. 6, pp. 641–647, 2010.
- O. Söderberg, M. Gullberg, M. Jarvius et al., “Direct observation of individual endogenous protein complexes in situ by proximity ligation,” Nature Methods, vol. 3, no. 12, pp. 995–1000, 2006.
- Y. Xue, J. Ren, X. Gao, C. Jin, L. Wen, and X. Yao, “GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy,” Molecular and Cellular Proteomics, vol. 7, no. 9, pp. 1598–1606, 2008.
- C. Yu, W. Han, T. Shi et al., “PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway,” Cellular Signalling, vol. 20, no. 12, pp. 2208–2220, 2008.
- H. Gehart, S. Kumpf, A. Ittner, and R. Ricci, “MAPK signalling in cellular metabolism: stress or wellness?” EMBO Reports, vol. 11, no. 11, pp. 834–840, 2010.
- G. Y. Carmen and S. M. Víctor, “Signalling mechanisms regulating lipolysis,” Cell Signal, vol. 18, no. 4, pp. 401–408, 2006.
- A. Brobeil, M. Bobrich, and M. Wimmer, “Protein tyrosine phosphatase interacting protein 51—a jack-of-all-trades protein,” Cell and Tissue Research, vol. 344, no. 2, pp. 189–205, 2011.
- J. J. Berger and R. J. Barnard, “Effect of diet on fat cell size and hormone-sensitive lipase activity,” Journal of Applied Physiology, vol. 87, no. 1, pp. 227–232, 1999.
- T. Kadowaki, K. Hara, T. Yamauchi, Y. Terauchi, K. Tobe, and R. Nagai, “Molecular mechanism of insulin resistance and obesity,” Experimental Biology and Medicine, vol. 228, no. 10, pp. 1111–1117, 2003.
- S. B. Peres, S. M. F. de Moraes, C. E. M. Costa et al., “Endurance exercise training increases insulin responsiveness in isolated adipocytes through IRS/PI3-kinase/Akt pathway,” Journal of Applied Physiology, vol. 98, no. 3, pp. 1037–1043, 2005.
- J. E. Campbell, S. Fediuc, T. J. Hawke, and M. C. Riddell, “Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis,” Metabolism, vol. 58, no. 5, pp. 651–660, 2009.
- S. Collins, W. Cao, and J. Robidoux, “Learning new tricks from old dogs: β-adrenergic receptors teach new lessons on firing up adipose tissue metabolism,” Molecular Endocrinology, vol. 18, no. 9, pp. 2123–2131, 2004.